Phylos Overview
- Status
- Private
- Employees
- 28
- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $7.6M
- Investors
- 12
Phylos General Information
Description
Operator of an agricultural genomics company intended to enhance the next generation of hemp and cannabis. The company offers a suite of tools using modern molecular genetics and computational biology to provide breeding and research services, thereby enabling cannabis growers and cultivators to understand the breadth of genetics in their catalog, evaluate the development of additional varieties and drive business growth.
Contact Information
Website
www.phylos.bio
Formerly Known As
Phylos Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Primary Office
- 959 South East Division Street
- Suite 420
- Portland, OR 97214
- United States
+1 (503) 000-0000
Phylos Timeline
Phylos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 01-Feb-2022 | $7.6M | 000.00 | Completed | Generating Revenue | |
| 8. Later Stage VC | 04-May-2021 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 7. Later Stage VC | 26-Jan-2021 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 6. Later Stage VC (Series B1) | 29-Apr-2020 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series C) | 15-Jan-2019 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 4. Accelerator/Incubator | 00.00 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 17-Jan-2014 | 000 | 00.00 | 00.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A1) | 30-Mar-2011 | $1000K | $2.4M | 000 | Completed | Startup |
| 1. Early Stage VC (Series A) | 14-Nov-2008 | $1.4M | $1.4M | 00.00 | Completed | Startup |
Phylos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 00,000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | ||
| Series B | 000,000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | ||
| Series A1 | 109,811 | $19.93 | $19.93 | 1x | $19.93 | 12.9% | ||
| Series A | 355,716 | $19.93 | $19.93 | $19.93 | 41.79% |
Phylos Patents
Phylos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200329658-A1 | Hemp variety nbs cbd-1 | Pending | 21-Nov-2019 | 00000000 |
Phylos Executive Team (14)
Phylos Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Patterson | Phylos | Board Member | 000 0000 |
| Lada Rasochova Ph.D | Self | Board Member & Advisor | 000 0000 |
| Mina Mishrikey | Self | Board Member | 000 0000 |
| Nishan Karassik | Phylos | Co-Founder, Chief Innovation Officer & Board Member | 000 0000 |
| Ralph Risch | Phylos | Chief Executive Officer, Chief Operating Officer & Board Member | 000 0000 |
Phylos Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPhylos Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Accomplice VC | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Merida Capital Holdings | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Arcadian Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Artemis Growth Partners | Impact Investing | Minority | 000 0000 | 000000 0 | |
| Big Rock | Venture Capital | Minority | 000 0000 | 000000 0 |